Phase II clinical trial of S‐1 plus nanoparticle albumin‐bound paclitaxel in untreated patients with metastatic gastric cancer

The present study is the first phase II clinical trial aimed to evaluate the efficacy and safety of S‐1 plus nanoparticle albumin‐bound paclitaxel (Nab‐PTX) as first‐line chemotherapy for advanced gastric cancer (AGC). Previously untreated patients with metastatic gastric adenocarcinoma received S‐1...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Sci
Autores principales: He, Ming‐ming, Wang, Feng, Jin, Ying, Yuan, Shu‐qiang, Ren, Chao, Luo, Hui‐yan, Wang, Zhi‐qiang, Qiu, Miao‐zhen, Wang, Zi‐xian, Zeng, Zhao‐lei, Li, Yu‐hong, Wang, Feng‐hua, Zhang, Dong‐sheng, Xu, Rui‐hua
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6215885/
https://ncbi.nlm.nih.gov/pubmed/30281875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13813
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares